Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0128 | 0.0213 | 0.2223 |
Schistosoma mansoni | hypothetical protein | 0.0464 | 0.0906 | 0.3411 |
Toxoplasma gondii | 3-ketoacyl-(acyl-carrier-protein) reductase | 0.008 | 0.0115 | 0.048 |
Treponema pallidum | replicative DNA helicase (dnaB) | 0.1289 | 0.2609 | 0.5 |
Mycobacterium tuberculosis | Possible 20-beta-hydroxysteroid dehydrogenase FabG3 (cortisone reductase) ((R)-20-hydroxysteroid dehydrogenase) | 0.008 | 0.0115 | 0.0241 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.006 | 0.062 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0092 | 0.014 | 0.0099 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.0464 | 0.0906 | 0.0857 |
Loa Loa (eye worm) | oxidoreductase | 0.008 | 0.0115 | 0.1203 |
Toxoplasma gondii | 2,4-dienoyl CoA reductase 2, peroxisomal family protein | 0.0092 | 0.014 | 0.0583 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.0464 | 0.0906 | 0.0857 |
Mycobacterium tuberculosis | Probable dehydrogenase/reductase | 0.008 | 0.0115 | 0.0241 |
Wolbachia endosymbiont of Brugia malayi | replicative DNA helicase | 0.1289 | 0.2609 | 1 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.0464 | 0.0906 | 0.3411 |
Leishmania major | dehydrogenase/oxidoreductase-like protein | 0.008 | 0.0115 | 0.8242 |
Echinococcus granulosus | dual specificity protein phosphatase | 0.0489 | 0.096 | 0.0911 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0128 | 0.0214 | 0.0397 |
Trypanosoma brucei | beta-ketoacyl-ACP reductase | 0.008 | 0.0115 | 0.8242 |
Leishmania major | trypanothione reductase | 0.0051 | 0.0054 | 0.3847 |
Chlamydia trachomatis | replicative DNA helicase | 0.1289 | 0.2609 | 1 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0116 | 0.0188 | 0.0524 |
Schistosoma mansoni | Replicative DNA helicase | 0.1289 | 0.2609 | 1 |
Leishmania major | oxidoreductase-like protein | 0.0092 | 0.014 | 1 |
Mycobacterium leprae | PROBABLE REPLICATIVE DNA HELICASE DNAB replicative DNA helicase | 0.1289 | 0.2609 | 1 |
Loa Loa (eye worm) | retinol dehydrogenase 12 | 0.008 | 0.0115 | 0.1203 |
Trypanosoma brucei | trypanothione reductase | 0.0051 | 0.0054 | 0.3847 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0116 | 0.0188 | 0.0524 |
Plasmodium vivax | glutathione reductase, putative | 0.0051 | 0.0054 | 0.0224 |
Mycobacterium ulcerans | enoyl-(acyl carrier protein) reductase | 0.1188 | 0.2402 | 0.9171 |
Wolbachia endosymbiont of Brugia malayi | enoyl-ACP reductase | 0.1188 | 0.2402 | 0.9171 |
Mycobacterium leprae | NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) | 0.1188 | 0.2402 | 0.9171 |
Brugia malayi | Thioredoxin reductase | 0.0051 | 0.0054 | 0.0561 |
Schistosoma mansoni | hypothetical protein | 0.0464 | 0.0906 | 0.3411 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0116 | 0.0188 | 0.0524 |
Mycobacterium tuberculosis | NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) | 0.1188 | 0.2402 | 0.9191 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.006 | 0.062 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.006 | 0.062 |
Giardia lamblia | Dual specificity phosphatase, catalytic | 0.0489 | 0.096 | 0.5 |
Mycobacterium tuberculosis | Probable replicative DNA helicase DnaB | 0.1289 | 0.2609 | 1 |
Schistosoma mansoni | 3-oxoacyl-[ACP] reductase | 0.008 | 0.0115 | 0.0351 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0116 | 0.0188 | 0.0524 |
Schistosoma mansoni | apoptosis regulator bax | 0.0464 | 0.0906 | 0.3411 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.008 | 0.0115 | 0.0241 |
Brugia malayi | glutathione reductase | 0.0051 | 0.0054 | 0.0561 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.0115 | 0.1203 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0116 | 0.0188 | 0.029 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0128 | 0.0214 | 0.0629 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.008 | 0.0115 | 0.1203 |
Toxoplasma gondii | short chain dehydrogenase family protein, putative | 0.008 | 0.0115 | 0.048 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0673 | 0.1338 | 0.1291 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 0.029 | 0.1028 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0128 | 0.0213 | 0.2223 |
Leishmania major | 3-oxoacyl-ACP reductase, putative | 0.008 | 0.0115 | 0.8242 |
Schistosoma mansoni | hypothetical protein | 0.0464 | 0.0906 | 0.3411 |
Plasmodium vivax | enoyl-acyl carrier protein reductase | 0.1188 | 0.2402 | 1 |
Trypanosoma brucei | pteridine reductase 1 | 0.008 | 0.0115 | 0.8242 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0673 | 0.1338 | 0.5081 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0051 | 0.0054 | 0.0224 |
Plasmodium vivax | 3-oxoacyl-[acyl-carrier-protein] reductase, putative | 0.008 | 0.0115 | 0.048 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.0025 | 0.0257 |
Leishmania major | pteridine reductase 1 | 0.0092 | 0.014 | 1 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0128 | 0.0214 | 0.0629 |
Brugia malayi | Dual specificity phosphatase, catalytic domain containing protein | 0.0489 | 0.096 | 1 |
Chlamydia trachomatis | enoyl-acyl-carrier protein reductase | 0.1188 | 0.2402 | 0.9171 |
Echinococcus multilocularis | 3 oxoacyl acyl carrier protein reductase | 0.008 | 0.0115 | 0.0062 |
Loa Loa (eye worm) | glutathione reductase | 0.0051 | 0.0054 | 0.0561 |
Brugia malayi | MH2 domain containing protein | 0.0128 | 0.0213 | 0.2223 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0673 | 0.1338 | 0.1291 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0092 | 0.014 | 0.0099 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.487 | 1 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.0051 | 0.0054 | 0.0224 |
Loa Loa (eye worm) | twinkle helicase | 0.0368 | 0.0709 | 0.7391 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 0.029 | 0.1028 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0092 | 0.014 | 0.0337 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.008 | 0.0115 | 0.0241 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0116 | 0.0188 | 0.0524 |
Echinococcus multilocularis | geminin | 0.0165 | 0.029 | 0.0238 |
Onchocerca volvulus | 0.0489 | 0.096 | 1 | |
Loa Loa (eye worm) | dual specificity phosphatase | 0.0489 | 0.096 | 1 |
Schistosoma mansoni | dual specificity protein phosphatase | 0.0489 | 0.096 | 0.3618 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.008 | 0.0115 | 0.8242 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0051 | 0.0054 | 0.0561 |
Mycobacterium ulcerans | replicative DNA helicase DnaB | 0.1289 | 0.2609 | 1 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.008 | 0.0115 | 0.0241 |
Toxoplasma gondii | enoyl-acyl carrier reductase ENR | 0.1188 | 0.2402 | 1 |
Trypanosoma brucei | oxidoreductase-like protein | 0.0092 | 0.014 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0092 | 0.014 | 0.0099 |
Mycobacterium ulcerans | 3-alpha-hydroxysteroid dehydrogenase | 0.0092 | 0.014 | 0.0099 |
Onchocerca volvulus | 0.0092 | 0.014 | 0.0291 | |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.008 | 0.0115 | 0.1203 |
Echinococcus granulosus | geminin | 0.0165 | 0.029 | 0.0238 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.008 | 0.0115 | 0.8242 |
Entamoeba histolytica | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.008 | 0.0115 | 0.5 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.0464 | 0.0906 | 0.9444 |
Plasmodium falciparum | glutathione reductase | 0.0051 | 0.0054 | 0.0224 |
Schistosoma mansoni | dihydropteridine reductase | 0.008 | 0.0115 | 0.0351 |
Plasmodium falciparum | enoyl-acyl carrier reductase | 0.1188 | 0.2402 | 1 |
Echinococcus multilocularis | dual specificity protein phosphatase | 0.0489 | 0.096 | 0.0911 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.006 | 0.062 |
Plasmodium falciparum | thioredoxin reductase | 0.0051 | 0.0054 | 0.0224 |
Leishmania major | dehydrogenase/oxidoreductase-like protein | 0.008 | 0.0115 | 0.8242 |
Mycobacterium tuberculosis | Probable 3-oxoacyl-[acyl-carrier protein] reductase FabG2 (3-ketoacyl-acyl carrier protein reductase) | 0.008 | 0.0115 | 0.0241 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.008 | 0.0115 | 0.0241 |
Trichomonas vaginalis | hypothetical protein | 0.1188 | 0.2402 | 0.5 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.0092 | 0.014 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0464 | 0.0906 | 0.9444 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0051 | 0.0054 | 0.3847 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.0464 | 0.0906 | 0.9444 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0025 | 0.0257 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.008 | 0.0115 | 0.0241 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0128 | 0.0214 | 0.0629 |
Plasmodium falciparum | 3-oxoacyl-[acyl-carrier-protein] reductase | 0.008 | 0.0115 | 0.048 |
Echinococcus granulosus | 3 oxoacyl acyl carrier protein reductase | 0.008 | 0.0115 | 0.0062 |
Mycobacterium tuberculosis | Probable reductase | 0.0116 | 0.0188 | 0.0524 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.008 | 0.0115 | 0.1203 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.